What’s new and what’s next for gene therapy in Pompe disease?

Abstract excerpt

INTRODUCTION: Pompe disease is an autosomal recessive disorder caused by a deficiency of acid-α-glucosidase (GAA), an enzyme responsible for hydrolyzing lysosomal glycogen. A lack of GAA leads to accumulation of glycogen in the lysosomes of cardiac, skeletal, and smooth muscle cells, as well as in the central and peripheral nervous system. Enzyme replacement therapy has been the standard of care for 15 years and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glycogen Storage Diseases and Myoclonus
• Share to Lysosomal Storage Disorders Research
• Share to Virus-based gene therapy research